+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Anthelmintic Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030

  • ID: 5136499
  • Report
  • May 2020
  • Region: Global
  • 247 pages
  • Transparency Market Research
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Bayer AG
  • Cipla Inc.
  • GlaxoSmithKline plc
  • Novartis AG
  • Zoetis, Inc.
  • MORE
Anthelmintic Drugs Market - Scope of the Report

This report on the global anthelmintic drugs market studies the past as well as current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period 2020 to 2030 The report provides the overall revenue of the global anthelmintic drugs market for the period 2018-2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global anthelmintic drugs market for the forecast period.

The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global anthelmintic drugs market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts also employed a combination of the top-down and bottom-up approaches to study various phenomena in the global anthelmintic drugs market.

The report delves into the competition landscape of the global anthelmintic drugs market. Key players operating in the global anthelmintic drugs market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the global anthelmintic drugs market report.

Key Questions Answered in Anthelmintic Drugs Market Report
  • What is the sales/revenue generated by the global anthelmintic drugs market across all the regions during the forecast period?
  • What are the key trends in the global anthelmintic drugs market?
  • What are the major drivers, restraints, and opportunities in the global market?
  • Which region is set to expand at the fastest CAGR during the forecast period?
  • Which segment will have the highest revenue globally in 2030 and which drug class will expand at the fastest CAGR during the forecast period?
Anthelmintic Drugs Market - Research Objectives and Research Approach

The comprehensive report on the global anthelmintic drugs market begins with an overview of the market, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives of the study and healthcare compliances laid down by accredited agencies in the purview of research in the global anthelmintic drugs market. It is followed by market introduction, market dynamics, and an overview of the global anthelmintic drugs market, which includes analysis of market drivers, restraints, and trends affecting the growth of the market. Furthermore, Y-o-Y analysis with elaborate insights has been provided to understand the Y-o-Y trends of the anthelmintic drugs market. The next section of the global anthelmintic drugs market report highlights the USPs, which include epidemiology of helminthic infections across globe, key industry events (product launches, approvals, acquisitions, mergers, collaborations, etc.), and impact of COVID-19 on the anthelmintic drugs market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into smaller sections. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

Revenue generated by key anthelmintic drugs manufacturers has been mapped to ascertain the size of the global anthelmintic drugs market in terms of value. The forecast presented here assesses the total revenue generated in the anthelmintic drugs market. In order to provide an accurate forecast, we initiated by sizing up the current anthelmintic drugs market with the help of the parent market.

The report analyzes the global anthelmintic drugs market in terms of drug class, route of administration, application, target pathogen, distribution channel, and region. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2030 has been provided. These valuable insights would help market stakeholders in making informed business decisions for investments in the global anthelmintic drugs market.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Bayer AG
  • Cipla Inc.
  • GlaxoSmithKline plc
  • Novartis AG
  • Zoetis, Inc.
  • MORE
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Anthelmintic Drugs Market

4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.4. Global Anthelmintic Drugs Market Analysis and Forecast, 2018-2030

5. Key Insights
5.1. Epidemiology of Helminthic Infections
5.2. Key Industry Events (Product Launch, Approval, Acquisition, Merger, Collaboration, etc.)
5.3. Impact of COVID-19 on Anthelmintic Drugs Market

6. Global Anthelmintic Drugs Market Analysis and Forecast, by Drug Class
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Anthelmintic Drugs Market Value Forecast, by Drug Class, 2018-2030
6.4. Market Attractiveness Analysis, by Drug Class

7. Global Anthelmintic Drugs Market Analysis and Forecast, by Route of Administration
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Anthelmintic Drugs Market Value Forecast, by Route of Administration, 2018-2030
7.4. Market Attractiveness Analysis, by Route of Administration

8. Global Anthelmintic Drugs Market Analysis and Forecast, by Application
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Anthelmintic Drugs Market Value Forecast, by Application, 2018-2030
8.4. Market Attractiveness Analysis, by Application

9. Global Anthelmintic Drugs Market Analysis and Forecast, by Target Pathogen
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Anthelmintic Drugs Market Value Forecast, by Target Pathogen, 2018-2030
9.4. Market Attractiveness Analysis, by Target Pathogen

10. Global Anthelmintic Drugs Market Analysis and Forecast, by Distribution Channel
10.1. Introduction & Definition
10.2. Key Findings / Developments
10.3. Anthelmintic Drugs Market Value Forecast, by Distribution Channel, 2018-2030
10.4. Market Attractiveness Analysis, by Distribution Channel

11. Global Anthelmintic Drugs Market Analysis and Forecast, by Region
11.1. Key Findings
11.2. Anthelmintic Drugs Market Value Forecast, by Region
11.3. Market Attractiveness Analysis, by Region

12. North America Anthelmintic Drugs Market Analysis and Forecast
12.1. Introduction
12.2. North America Anthelmintic Drugs Market Value Forecast, by Drug Class, 2018-2030
12.3. North America Anthelmintic Drugs Market Value Forecast, by Route of Administration, 2018-2030
12.4. North America Anthelmintic Drugs Market Value Forecast, by Application, 2018-2030
12.5. North America Anthelmintic Drugs Market Value Forecast, by Target Pathogen, 2018-2030
12.6. North America Anthelmintic Drugs Market Value Forecast, by Distribution Channel, 2018-2030
12.7. North America Anthelmintic Drugs Market Value Forecast, by Country, 2018-2030
12.8. North America Anthelmintic Drugs Market Attractiveness Analysis

13. Europe Anthelmintic Drugs Market Analysis and Forecast
13.1. Introduction
13.2. Europe Anthelmintic Drugs Market Value Forecast, by Drug Class, 2018-2030
13.3. Europe Anthelmintic Drugs Market Value Forecast, by Route of Administration, 2018-2030
13.4. Europe Anthelmintic Drugs Market Value Forecast, by Application, 2018-2030
13.5. Europe Anthelmintic Drugs Market Value Forecast, by Target Pathogen, 2018-2030
13.6. Europe Anthelmintic Drugs Market Value Forecast, by Distribution Channel, 2018-2030
13.7. Europe Anthelmintic Drugs Market Value Forecast, by Country/Sub-region, 2018-2030
13.8. Europe Anthelmintic Drugs Market Attractiveness Analysis

14. Asia Pacific Anthelmintic Drugs Market Analysis and Forecast
14.1. Introduction
14.2. Asia Pacific Anthelmintic Drugs Market Value Forecast, by Drug Class, 2018-2030
14.3. Asia Pacific Anthelmintic Drugs Market Value Forecast, by Route of Administration, 2018-2030
14.4. Asia Pacific Anthelmintic Drugs Market Value Forecast, by Application, 2018-2030
14.5. Asia Pacific Anthelmintic Drugs Market Value Forecast, by Target Pathogen, 2018-2030
14.6. Asia Pacific Anthelmintic Drugs Market Value Forecast, by Distribution Channel, 2018-2030
14.7. Asia Pacific Anthelmintic Drugs Market Value Forecast, by Country/Sub-region, 2018-2030
14.8. Asia Pacific Anthelmintic Drugs Market Attractiveness Analysis

15. Latin America Anthelmintic Drugs Market Analysis and Forecast
15.1. Introduction
15.2. Latin America Anthelmintic Drugs Market Value Forecast, by Drug Class, 2018-2030
15.3. Latin America Anthelmintic Drugs Market Value Forecast, by Route of Administration, 2018-2030
15.4. Latin America Anthelmintic Drugs Market Value Forecast, by Application, 2018-2030
15.5. Latin America Anthelmintic Drugs Market Value Forecast, by Target Pathogen, 2018-2030
15.6. Latin America Anthelmintic Drugs Market Value Forecast, by Distribution Channel, 2018-2030
15.7. Latin America Anthelmintic Drugs Market Value Forecast, by Country/Sub-region, 2018-2030
15.8. Latin America Anthelmintic Drugs Market Attractiveness Analysis

16. Middle East & Africa Anthelmintic Drugs Market Analysis and Forecast
16.1. Introduction
16.2. Middle East & Africa Anthelmintic Drugs Market Value Forecast, by Drug Class, 2018-2030
16.3. Middle East & Africa Anthelmintic Drugs Market Value Forecast, by Route of Administration, 2018-2030
16.4. Middle East & Africa Anthelmintic Drugs Market Value Forecast, by Application, 2018-2030
16.5. Middle East & Africa Anthelmintic Drugs Market Value Forecast, by Target Pathogen, 2018-2030
16.6. Middle East & Africa Anthelmintic Drugs Market Value Forecast, by Distribution Channel, 2018-2030
16.7. Middle East & Africa Anthelmintic Drugs Market Value Forecast, by Country/Sub-region, 2018-2030
16.8. Middle East & Africa Anthelmintic Drugs Market Attractiveness Analysis

17. Competitive Landscape
17.1. Market Player - Competition Matrix (By Tier and Size of companies)
17.2. Company Profiles
Note: Product cover images may vary from those shown
3 of 3
  • Novartis AG
  • Zoetis, Inc.
  • Amneal Pharmaceuticals Inc.
  • Cipla Inc.
  • Janssen Pharmaceuticals, Inc. (Johnson & Johnson)
  • Sun Pharmaceutical Industries Ltd
  • GlaxoSmithKline plc
  • Bayer AG
  • Merck & Co. Inc. (Intervet Inc.)
  • Boehringer Ingelheim International GmbH
Note: Product cover images may vary from those shown
Adroll
adroll